Who we are

Grow, track, and analyze human brain tissue with effortless, intuitive automation.

The FDA's Modernization Acts 2.0 and 3.0 signify a prominent shift toward alternative preclinical models, promoting more predictive and ethical approaches to drug development. Researchers face significant challenges in cultivating, maintaining, and analyzing human 3D tissue culture disease models. Open Culture Science alleviates these with an automated microfluidic platform that enables the development and real-time analysis of organ-specific human tissues derived from stem cells. This technology allows precise monitoring of moment-by-moment responses to pharmaceutical compounds, advancing drug discovery with unprecedented accuracy and efficiency.